AIDSLink Brief
Breaking through Barriers: Delivering Essential Medicines in the Developing World Supply chains featured in Global Health Council's AIDSLink.
|
AIDSLink Brief - Mozambique
Coordinating Donor Funds to Scale-Up AIDS Treatment in Mozambique featured in Global Health Council's AIDSLink
|
AIDSLink Brief - Guyana
Guyana Confronts Supply Chain Challenges in Scaling-Up featured in Global Health Council's AIDSLink
|
AIDSLink Brief - Forging the HIV/AIDS Chain
Forging the HIV/AIDS Chain: Securing Safe Passage of Drug Supply in Africa
|
Antiretroviral Treatment of Adult HIV Infection: 2008 Recommendations of the International AIDS Society USA Panell
The availability of new antiretroviral drugs and formulations, including drugs in new classes, and recent data on treatment choices for antiretroviral-naive and -experienced patients warrant an update of the International AIDS Society–USA guidelines for the use of antiretroviral therapy in adult human immunodeficiency virus (HIV) infection.
|
Behavior Change (Re)Considerations for the 21st Century
The Global HIV Prevention Working Group is a panel of over 50 leading public health experts, clinicians, biomedical and behavioral researchers, advocates, and people affected by HIV/AIDS, convened by the Bill & Melinda Gates Foundation and the Henry J. Kaiser Family Foundation.This report from the Global HIV Prevention Working Group (PWG) focuses specifically on behavioral HIV prevention. The report surveys what we know about the effectiveness of behavior change strategies, what we still need to learn, and what we need to do to advance such efforts in coming years.
|
The Contraceptive Forecasting Handbook
The Contraceptive Forecasting Handbook for Family Planning and HIV/AIDS Prevention Programs is designed as a reference book for forecasting commodity needs for family planning and HIV/AIDS prevention programs.
|
Delivering HIV/AIDS Products to Customers
Lessons Learned in Supply Chain Management. Drawing on examples from interventions in many of the 18 countries mentioned above, this paper illustrates how several unique characteristics of HIV/AIDS programs or commodities affect supply chain management.
|
Fact Sheet on Reauthorizing PEPFAR
On July 30, 2008, President George W. Bush signed into law H.R. 5501, the Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008. This legislation responds to the President’s call last year to expand the U.S. Government commitment to this successful program for five additional years, from 2009 through 2013.
|
Focusing on Family Planning Lessens HIV Impact
"Family Planning Choices for Women With HIV," published by the INFO Project at Johns Hopkins Bloomberg School of Public Health, Center for Communication Programs.
|
Guidelines for Managing the HIV/AIDS Supply Chain
The Guidelines for Managing the HIV/AIDS Supply Chain is a set of references for managers working to ensure a continuous supply of quality HIV/AIDS commodities to programs. The Guidelines highlight lessons learned from JSI and DELIVER advisors experience designing, implementing, and improving HIV/AIDS supply chains in resource limited settings.
|
Guide for Quantifying HIV Tests
This guide for quantifying HIV tests draws from the collective experience of DELIVER logistics advisors who have been involved in a range of activities to improve management of the supply chains for HIV/AIDS commodities in several countries that are hardest hit by the epidemic. The list of countries includes Ghana, Kenya, Malawi, Mozambique, Nepal, Nigeria, South Africa, Tanzania, Uganda, Ukraine, Zambia, and Zimbabwe.
|
Guide for Quantifying ARV Drugs
This guide for quantifying ARV drugs draws from the collective experience of DELIVER logistics advisors who have been involved in a range of activities to improve management of the supply chains for HIV/AIDS commodities in several countries that are hardest hit by the epidemic.
|
Guidelines for the Storage of Essential Medicines and Other Health Commodities
A practical reference for those managing or involved in setting up a storeroom or warehouse. The guide contains written directions and clear illustrations on receiving and arranging commodities; special storage conditions; tracking commodities; maintaining the quality of the products; constructing and designing a medical store; waste management; and resources.
|
Guidelines for Warehousing Health Commodities
Guidelines for Warehousing Health Commodities provides up-to-date information on all aspects of warehousing. The guidelines consist of four sections—human resource, layout planning, racking systems and material handling equipment, and warehouse management system.
|
HHS AIDSInfo Guide
Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents.
|
Living well with HIV/AIDS
A manual from the World Health Organization and Food and Agriculture Organization of the United Nations on nutritional care and support for people living with HIV/AIDS.
|
NIH Guidelines
Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection
|
PEPFAR Five Year Strategy
The Five-Year Strategy of the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) outlines the high-level direction of the program for its next phase. This strategy reflects lessons learned in the first five years of the program, expands existing commitments around service delivery, and places a heightened emphasis on sustainability.
|
PEPFAR - HIV AIDS and the US Government's Response: The Power of Partnerships
Overview of PEPFAR goals, countries in where PEPFAR is working, approaches to prevent transmission and strategy for how partnerships can help.
|
PEPFAR Annual Report to Congress 2009
Celebrating Life: The U.S. President’s Emergency Plan for AIDS Relief
|
|
Pipeline User's Guide
A software tool designed to help program managers regularly monitor the status of their product pipelines and product.
|
Policy Guidelines for Collaborative TB and HIV Services for Injecting and Other Drug Users, An Integrated Approach
These guidelines are intended for professionals dealingwith the drug users who have the most problematicpatterns of use and who have the greatest riskof HIV and TB, especially those who inject drugs.
|
Power of Partnerships
Fourth Annual Report to Congress on PEPFAR (2008) outlines the role of America's partnerships in the worldwide fight against HIV/AIDS.
|
SCMS: Strengthening Supply Chains in the Global Response to HIV/AIDS
Download InterAction's newsletter Monday Developments which features an article on supply chains and SCMS efforts. InterAction is the largest alliance of US-based international development and humanitarian nongovernmental organizations.
|
The Deadly World of Fake Drugs
Foreign Policy articles which examines the fake druge industry and what is being done to identify counterfeit medicine.
|
The Global Economic Crisis and HIV Prevention and Treatment Programmes: Vulnerabilities and Impact
The global economic crisis threatens recent gains in health and poverty reduction in developing countries. What can be done to avoid negative impacts? This documents presents findings based on information collected in late March 2009 from respondents in 71 countries (in which 3.4 million people are on antiretroviral treatment)
|
Quantification of Health Commodities: HIV Test Kit Companion Guide
The primary focus and purpose of this companion guide is to supplement the general guide on Quantification of Health Commodities: A Guide to Forecasting and Supply Planning for Procurement by describing in detail the specific methodology for forecasting consumption of HIV test kits as a critical step in the overall quantification process.
|
Lab Logistics Handbook: A Guide to Designing and Managing Laboratory Logistics Systems
This document describes the function and organization of laboratory services and the commodities needed for laboratory services, and it discusses supply chain considerations for management of laboratory commodities.
|
The Treatment Timebomb
The report describes how by 2030 over 50 million people will need HIV treatment compared to just 9 million who need it today.
|
U4 Brief
This report, Anti-Corruption in the Health Sector: Preventing Drug Diversion through Supply Chain Management, was written for U4 Anti-Corruption Resource Center and highlights efforts to increase transparency and provide a secure, high-quality supply of HIV/AIDS drugs to developing countries in Africa and Asia.
|
UNDAIDS Annual Report
Launched in January 1996, the Joint United Nations Programme on HIV/AIDS (UNAIDS) supports and coordinates the efforts of 10 cosponsoring United Nations (UN) system organizations and works with a wide range of other partners in the global response to AIDS.
|
UNAIDS Fact Sheet
Key facts by region – 2007 AIDS Epidemic Update
|
UNAIDS and WHO Report: 2009 AIDS Epedmic UpdateEpedmic Update
This report summarizes the latest data on the epidemiology of HIV. The epidemiological estimates in this report reflect continued improvement in national HIV surveillancesystems and estimation methodology
|
USAID: Assessing Supply Chains for HIV/AIDS Commodities
This paper presents technical guidance for assessing supply chain management (SCM) systems for HIV/AIDS programs in the context of system design, implementation, monitoring, and evaluation.
|
USAID Issue Brief: Delivering a Lifeline: Comprehensive Antiretroviral Therapy Programs
Antiretroviral drugs are just one aspect of a comprehensive HIV/AIDS treatment, care, and support program that includes meeting the medical, psychological, socioeconomic, and legal needs of those affected by the disease. In USAID’s ART programs, the treatment component consists of the use of at least three ARV medications. The objective of the drug component is to suppress HIV replication and slow the progression of HIV disease.
|
Towards universal access: scaling up priority HIV/AIDS interventions in the health sector
The close of 2007 marks an important step in the history of the HIV/AIDS epidemic. Nearly 3 million people are now receiving anti-retroviral therapy (ART) in low- and middle-income countries, according to a new report jointly launched today by WHO, UNAIDS and UNICEF.
|
Using mobile phones in HIV care and prevention
This edition of HIV & AIDS Treatment in Practice explores the potential of mobile phones and presents case studies to illustrate the ways in which mobile phone technology is already being used in HIV treatment and care. HATIP also includes a monthly column focused on advancing the integration of HIV and TB services, exploring the challenges and practical solutions to the implementation of TB/HIV collaborative activities, and improving the diagnosis and treatment of the more difficult-to-manage forms of TB that are common in people with HIV, including smear negative, extrapulmonary and drug resistant TB. This document is from NAM / www.aidsmap.com.
|
WHO’s AIDS Medicines and Diagnostics Service (AMDS) March 2008 Newsletter
A news-brief with information on key procurement and supply management related developments and activities by the AMDS team and partner organizations.
|
WHO, UNAIDS and UNICEF report Towards universal access: Scaling up priority HIV/AIDS interventions in the health sector
The close of 2007 marks an important step in the history of the HIV/AIDS epidemic. Nearly 3 million people are now receiving anti-retroviral therapy (ART) in low- and middle-income countries, according to a new report jointly launched today by WHO, UNAIDS and UNICEF.
|
WHO Technical Reference Group Report
Recommendations from the Reference Group, Pediatric HIV/ART Care Guideline Group Meeting
|
WHO Progress Report: Towards universal access: scaling up priority HIV/AIDS interventions in the health sector
Towards universal access: scaling up priority HIV/AIDS interventions in the health sector highlights other gains, including expanded HIV testing and counselling and improved access to services to prevent HIV transmission from mother to child
|
World Health Statistics 2008
The most recent available health statistics for WHO’s 193 Member States. This fourth edition includes 10 highlights of health statistics as well as data on an expanded set of over 70 key health indicators. The indicators were selected on the basis of their relevance to global health monitoring and considerations of data availability, accuracy and comparability among Member States.
|
